ConductScience.org, home

Paper22926596

Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women.

King AC and 7 others. J Clin Psychopharmacol, 2012. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. Papers, record 22926596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22926596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women.
PubMed
Journal
J Clin Psychopharmacol
PubMed
Year
2012
PubMed
Publication types
Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
2.78
iCite
Revised in PubMed
2024-05-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1King ACAndrea C
2Cao DDingcai
3O'Malley SSStephanie S
4Kranzler HRHenry R
5Cai XXiaochen
6deWit HHarriet
7Matthews AKAlicia K
8Stachoviak RJRyan J

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NaltrexoneMajor topic
Narcotic AntagonistsMajor topic
Smoking CessationMajor topic
Tobacco Use DisorderMajor topic
Administration, Oral
Adult
Cognitive Behavioral Therapy
Combined Modality Therapy
Dose-Response Relationship, Drug
Double-Blind Method
Female
Follow-Up Studies
Humans
Male
Middle Aged
Sex Factors
Time Factors
Tobacco Use Cessation Devices
Treatment Outcome
Weight Gain

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DA016834NIDA NIH HHSUnited StatesR01DA016834PubMed and NIHNIH RePORTER
ULI-RR024999NCRR NIH HHSUnited StatesUL1RR024999PubMed and NIHNIH RePORTER
UL1 RR024999NCRR NIH HHSUnited StatesUL1RR024999PubMed and NIHNIH RePORTER
R01-DA016834NIDA NIH HHSUnited StatesR01DA016834PubMed and NIHNIH RePORTER
P30 CA014599NCI NIH HHSUnited StatesP30CA014599PubMed and NIHNIH RePORTER
P30-CA14599NCI NIH HHSUnited StatesP30CA014599PubMed and NIHNIH RePORTER

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19851799Brain opioid receptor measurements by positron emission tomography in normal cycling women: relationship to luteinizing hormone pulsatility and gonadal steroid hormones.J Clin Endocrinol Metab1998https://conductscience.org/library/papers/9851799PubMed
220561758Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch.Drug Alcohol Depend2010https://conductscience.org/library/papers/20561758PubMed
315181019The epidemic of obesity.J Clin Endocrinol Metab2004https://conductscience.org/library/papers/15181019PubMed
417008194Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.Nicotine Tob Res2006https://conductscience.org/library/papers/17008194PubMed
515679745Cut-off levels for breath carbon monoxide as a marker for cigarette smoking.Addiction2005https://conductscience.org/library/papers/15679745PubMed
619593174Targeted naltrexone for problem drinkers.J Clin Psychopharmacol2009https://conductscience.org/library/papers/19593174PubMed
716567607A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.Arch Intern Med2006https://conductscience.org/library/papers/16567607PubMed
812745503Measures of abstinence in clinical trials: issues and recommendations.Nicotine Tob Res2003https://conductscience.org/library/papers/12745503PubMed
911260806Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings.Nicotine Tob Res2001https://conductscience.org/library/papers/11260806PubMed
1013688369An inventory for measuring depression.Arch Gen Psychiatry1961https://conductscience.org/library/papers/13688369PubMed
1112002168Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999.MMWR Morb Mortal Wkly Rep2002https://conductscience.org/library/papers/12002168PubMed
1219837518Acute HPA axis response to naltrexone differs in female vs. male smokers.Psychoneuroendocrinology2010https://conductscience.org/library/papers/19837518PubMed
1318629735Sex differences in long-term smoking cessation rates due to nicotine patch.Nicotine Tob Res2008https://conductscience.org/library/papers/18629735PubMed
1420678752Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [¹¹C]raclopride.Biol Psychiatry2010https://conductscience.org/library/papers/20678752PubMed
1520542391Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial.Drug Alcohol Depend2010https://conductscience.org/library/papers/20542391PubMed
1611687036Opioid antagonists for smoking cessation.Cochrane Database Syst Rev2001https://conductscience.org/library/papers/11687036PubMed
1718300538A pilot community-based intensive smoking cessation intervention in African Americans: feasibility, acceptability and early outcome indicators.J Natl Med Assoc2008https://conductscience.org/library/papers/18300538PubMed
1819910909Cigarette smoking among adults and trends in smoking cessation - United States, 2008.MMWR Morb Mortal Wkly Rep2009https://conductscience.org/library/papers/19910909PubMed
1910615738A randomized trial of naltrexone for smoking cessation.Addiction1999https://conductscience.org/library/papers/10615738PubMed
2019955525Forecasting the effects of obesity and smoking on U.S. life expectancy.N Engl J Med2009https://conductscience.org/library/papers/19955525PubMed

See all 44 referencesDownload CSV of references

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
40773739Use of Naltrexone for Patients With Stimulant Use Disorder in Malaysia: Protocol for a Retrospective Cohort Study.JMIR Res Protoc2025https://conductscience.org/library/papers/40773739PubMed
40660643Extended-release naltrexone versus oral naltrexone for substance use disorders: A systematic review and meta-analysis.Drug Alcohol Depend2025https://conductscience.org/library/papers/40660643PubMed
38872776Tobacco, cannabis, and the liver.Clin Liver Dis (Hoboken)2024https://conductscience.org/library/papers/38872776PubMed
38632388Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes.Nat Hum Behav2024https://conductscience.org/library/papers/38632388PubMed
38411974A systematic meta-epidemiologic review on nonabstinence-inclusive interventions for substance use: inclusion of race/ethnicity and sex assigned at birth/gender.Am J Drug Alcohol Abuse2024https://conductscience.org/library/papers/38411974PubMed
37034728Multi-ancestry meta-analysis of tobacco use disorder prioritizes novel candidate risk genes and reveals associations with numerous health outcomes.medRxiv2023https://conductscience.org/library/papers/37034728PubMed
36329195Elucidating the reinforcing effects of nicotine: a tribute to Nadia Chaudhri.Psychopharmacology (Berl)2023https://conductscience.org/library/papers/36329195PubMed
36200062Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review.Diabetes Metab Syndr Obes2022https://conductscience.org/library/papers/36200062PubMed
35470371The Effects of Menstrual Cycle Hormones on Responses to Varenicline and Naltrexone Among Female Heavy Drinking Smokers.Alcohol Alcohol2022https://conductscience.org/library/papers/35470371PubMed
34611902Interventions for preventing weight gain after smoking cessation.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/34611902PubMed
34182373Tobacco withdrawal increases junk food intake: The role of the endogenous opioid system.Drug Alcohol Depend2021https://conductscience.org/library/papers/34182373PubMed
34080890Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.Am J Psychiatry2021https://conductscience.org/library/papers/34080890PubMed
33831213Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial.Nicotine Tob Res2021https://conductscience.org/library/papers/33831213PubMed
32697329Nicotine increases alcohol self-administration in male rats via a μ-opioid mechanism within the mesolimbic pathway.Br J Pharmacol2020https://conductscience.org/library/papers/32697329PubMed
31206155Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial.Alcohol Alcohol2019https://conductscience.org/library/papers/31206155PubMed
31160146Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent.Drug Alcohol Depend2019https://conductscience.org/library/papers/31160146PubMed
30758525Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats.Psychopharmacology (Berl)2019https://conductscience.org/library/papers/30758525PubMed
30628813Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers.Exp Clin Psychopharmacol2019https://conductscience.org/library/papers/30628813PubMed
30169797Evaluation of a Randomized Clinical Trial Comparing the Effectiveness of a Culturally Targeted and Nontargeted Smoking Cessation Intervention for Lesbian, Gay, Bisexual, and Transgender Smokers.Nicotine Tob Res2019https://conductscience.org/library/papers/30169797PubMed
29563871Naltrexone and Bupropion Combination Treatment for Smoking Cessation and Weight Loss in Patients With Schizophrenia.Front Pharmacol2018https://conductscience.org/library/papers/29563871PubMed

See all 46 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
OPRM14988PubTator's text mininghttps://conductscience.org/library/genes/4988

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22926596

GET https://conductscience.org/api/papers/v1/22926596/references?page=2